Loes van Schie

963 total citations · 1 hit paper
8 papers, 472 citations indexed

About

Loes van Schie is a scholar working on Infectious Diseases, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Loes van Schie has authored 8 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Molecular Biology and 2 papers in Clinical Biochemistry. Recurrent topics in Loes van Schie's work include Tuberculosis Research and Epidemiology (2 papers), Advanced Glycation End Products research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Loes van Schie is often cited by papers focused on Tuberculosis Research and Epidemiology (2 papers), Advanced Glycation End Products research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Loes van Schie collaborates with scholars based in Belgium, Democratic Republic of the Congo and Germany. Loes van Schie's co-authors include Nico Callewaert, Bert Schepens, Gretel M. Torres, Kenny Roose, Daniel Wrapp, Dorien De Vlieger, Kizzmekia S. Corbett, Wander Van Breedam, Barney S. Graham and Xavier Saelens and has published in prestigious journals such as Cell, International Journal of Molecular Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Loes van Schie

8 papers receiving 468 citations

Hit Papers

Structural Basis for Potent Neutralization of Betacoronav... 2020 2026 2022 2024 2020 100 200 300

Peers

Loes van Schie
Gretel M. Torres United States
Fangzhu Zhao United States
Stephanie Giordano United States
Nicole Negron United States
Elzbieta Wloga United States
Mian Dai United Kingdom
Aidong Qu China
Frances Ayres South Africa
Gretel M. Torres United States
Loes van Schie
Citations per year, relative to Loes van Schie Loes van Schie (= 1×) peers Gretel M. Torres

Countries citing papers authored by Loes van Schie

Since Specialization
Citations

This map shows the geographic impact of Loes van Schie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loes van Schie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loes van Schie more than expected).

Fields of papers citing papers by Loes van Schie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loes van Schie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loes van Schie. The network helps show where Loes van Schie may publish in the future.

Co-authorship network of co-authors of Loes van Schie

This figure shows the co-authorship network connecting the top 25 collaborators of Loes van Schie. A scholar is included among the top collaborators of Loes van Schie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loes van Schie. Loes van Schie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Schie, Loes van, Wander Van Breedam, Bert Schepens, et al.. (2023). GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery. mAbs. 15(1). 2210709–2210709. 6 indexed citations
2.
Schie, Loes van, Simon Devos, Herlinde De Keersmaecker, et al.. (2022). Yeast-produced fructosamine-3-kinase retains mobility after ex vivo intravitreal injection in human and bovine eyes as determined by Fluorescence Correlation Spectroscopy. International Journal of Pharmaceutics. 621. 121772–121772. 2 indexed citations
3.
Schie, Loes van, Evelyn Plets, Marnik Vuylsteke, et al.. (2021). Exploration of Synergistic Action of Cell Wall-Degrading Enzymes against Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 65(10). e0065921–e0065921. 8 indexed citations
4.
Bruyne, Sander De, Loes van Schie, Filip De Somer, et al.. (2021). A Potential Role for Fructosamine-3-Kinase in Cataract Treatment. International Journal of Molecular Sciences. 22(8). 3841–3841. 12 indexed citations
5.
Wrapp, Daniel, Dorien De Vlieger, Kizzmekia S. Corbett, et al.. (2020). Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Cell. 181(5). 1004–1015.e15. 387 indexed citations breakdown →
7.
Vandepoele, Karl, Philippe Bianga Katchunga, Bram Laukens, et al.. (2016). A simple colorimetric assay for measuring fructosamine 3 kinase activity. Clinical Chemistry and Laboratory Medicine (CCLM). 55(1). 154–159. 3 indexed citations
8.
Verstraete, Kenneth, Loes van Schie, Yehudi Bloch, et al.. (2014). Structural basis of the proinflammatory signaling complex mediated by TSLP. Nature Structural & Molecular Biology. 21(4). 375–382. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026